Fujian Provincial Hospital
Fuzhou, Fujian, 350001, China
Location status: Recruiting
NCT Number: NCT06579937
The goal of this clinical trial is to learn the effect of intravenous esketamine in postoperative negative behavior changes in children compared to placebo (a look-alike substance that contains no drug). It will also learn about the effect of esketamine in emergence delirium. The main questions are:
Dose esketamine lower the incidence of postoperative negative behavior changes compared to placebo? Dose esketamine lower the incidence of emergence delirium compared to placebo? Researchers will compare esketamine to placebo to see if esketamine works to treat postoperative negative behavior change and emergence delirium.
Participants will:
Receive intravenous esketamine or placebo (a look-alike substance that contains no drug) during anesthesia induction; Fill in the Post hospitalization behavior questionnaire for ambulatory surgery postoperative 1, 7, and 30
Interested in participating?
Request Info3 year–7 year
All sexes
Interventional
Phase 4
Fuzhou, Fujian, 350001, China
Location status: Recruiting
Approximately half of children who undergo general anesthesia experience emergence delirium (ED) and postoperative negative behavioral changes (PNBC). There was a positive correlation between delirium during recovery and the change in negative behaviour after the operation.
Esketamine has sedative, analgesic and anti-traumatic stress effects. Based on literature analysis and preliminary trials, this study suggests that intraoperative use of low-dose esketamine may reduce the incidence of emergence delirium and postoperative negative behavior changes in children.
This prospective randomized controlled trial was conducted to compare the effect of intravenous esketamine in the incidence of emergence delirium and postoperative negative behavior changes in children compared to placebo (a look-alike substance that contains no drug) to provide a reference for optimizing clinical anesthesia medication regimens.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
During anesthesia induction, a 0.2 mg/kg esketamine bolus was administered intravenously.
Other names: esketamine hydrochloride injection
During anesthesia induction, a bolus of equal 0.9% saline was administered intravenously.
Time frame: Postoperative day 7
Postoperative negative behavior changes were assessed with Post Hospitalization Behavior Questionnaire for Ambulatory Surgery (PHBQ-AS).
Time frame: Postoperative day 1
Postoperative negative behavior changes were assessed with Post Hospitalization Behavior Questionnaire for Ambulatory Surgery (PHBQ-AS).
Time frame: Within 30 minutes after extubation
Emergence delirium was assessed using the Pediatric Anesthesia Emergence Delirium (PAED) scale (defined as a PAED score of ≥10).
Time frame: Postoperative day 30
Postoperative negative behavior changes were assessed with Post Hospitalization Behavior Questionnaire for Ambulatory Surgery (PHBQ-AS).
Time frame: Within 30 minutes after extubation
Postoperative pain intensity will be measured using the face, legs, activity, cry, and consolability scale.
Time frame: Before the intervention in holding area
Preoperative anxiety will be assessed using the modified Yale preoperative anxiety scale. Scores range from 23 to 100 with higher scores indicating greater anxiety.
Time frame: About up to 30 minutes postoperatively
Emergence time is defined as the interval from discontinuation of inhalation anesthetic to eye-opening on verbal command.
Time frame: Postoperative day 1
Parental satisfaction is self-reported using a five-point Likert scale (5=very satisfied, 4=satisfied, 3=neither satisfied nor dissatisfied, 2=dissatisfied, and 1=very dissatisfied).
Time frame: Up to 60 minutes postoperatively
Length of postanesthesia care unit (PACU) stay is defined as the time between arrival in the PACU and readiness for discharge from the PACU (defined as a modified Aldrete score of ≥9).
Time frame: Up to 24 hours postoperatively
Adverse events such as bradycardia, tachycardia, hypertension, hypotension, and hypoxia will be recorded during the trial.
Contact information is provided by the study sponsor or research team.
Sisi Chen, MD
CONTACT
Yusheng Yao, MD&PhD
CONTACT
Fujian Provincial Hospital
Other
Esketamine for the Prevention of Postoperative Behavioral Changes in Children Undergoing Tonsillectomy and/or Adenoidectomy: a Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06417125
Behavior Problem, Confusion
Fuzhou, Fujian, China
View Trial DetailsNCT07570160
Behavior Problem, Confusion
Nanjing, Jiangsu, China
View Trial DetailsNCT06170047
Behavior, Behavior Problem
Cincinnati, Ohio, United States
View Trial DetailsNCT05603000
Anxiety, Anxiety Disorders
Guelph, Ontario, Canada
View Trial Details